Compare ACIU & TAYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACIU | TAYD |
|---|---|---|
| Founded | 2003 | 1955 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 229.7M | 188.8M |
| IPO Year | 2015 | 1995 |
| Metric | ACIU | TAYD |
|---|---|---|
| Price | $2.12 | $58.18 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.58 | N/A |
| AVG Volume (30 Days) | ★ 195.8K | 24.2K |
| Earning Date | 11-04-2026 | 12-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.14 |
| Revenue | N/A | ★ $41,649,673.00 |
| Revenue This Year | $422.39 | $25.09 |
| Revenue Next Year | $377.85 | $23.22 |
| P/E Ratio | ★ N/A | $417.00 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.02 | $43.19 |
| 52 Week High | $3.90 | $90.37 |
| Indicator | ACIU | TAYD |
|---|---|---|
| Relative Strength Index (RSI) | 41.11 | 52.19 |
| Support Level | $2.09 | $51.63 |
| Resistance Level | $2.57 | $59.69 |
| Average True Range (ATR) | 0.19 | 1.68 |
| MACD | -0.00 | 0.32 |
| Stochastic Oscillator | 18.69 | 64.53 |
AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
Taylor Devices Inc is engaged in the design, development, manufacture and marketing of shock absorption, rate control, and energy storage devices for use in various types of machinery, equipment and structures. The company continues to develop new and technology products. The company manufactures and sells a group of very similar products that have many different applications for customers. These similar products are included in one of nine categories, namely, Seismic Dampers, Fluidicshoks, Crane and Industrial Buffers, Self-Adjusting Shock Absorbers, Liquid Die Springs, Vibration Dampers, Machined Springs, Custom Shock and Vibration Isolators, and Custom Actuators. It has presence in USA, Asia, and Others. Majority of revenue comes from USA.